Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness…
Pandemic-Inspired Thought Bubbles
0 Comments5 Minutes
As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share…
Notes from the Un-Empty Nest
0 Comments10 Minutes
Rare Diseases — It’s All About the Patient
0 Comments9 Minutes
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th anniversary of the Orphan Drug…
Planning Amidst the Mayhem
0 Comments6 Minutes
Maybe you noticed – 2020 was a crazy year. Like meeting the Pope or becoming a parent for the first time, the phrase "once in a lifetime" keeps…
My Big Announcement
0 Comments9 Minutes
Just Do It… the Best You Can with Compassion for Others AND Yourself
0 Comments6 Minutes
With six weeks left in the year, this newsletter should be all about getting in gear for the 2021 planning cycle. Or, maybe, it should be about Q1,…
Reverse Mentoring with Up-and-Coming Talent
0 Comments8 Minutes
In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why…
